Unbound MEDLINE

Two Distinct Major Facilitator Superfamily Drug Efflux Pumps Mediate Chloramphenicol Resistance in Streptomyces coelicolor. Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] Journal article

 
TitleTwo Distinct Major Facilitator Superfamily Drug Efflux Pumps Mediate Chloramphenicol Resistance in Streptomyces coelicolor.
Author(s)Vecchione JJ, Alexander B, Sello JK 
InstitutionDepartment of Chemistry, Brown University, 324 Brook Street, Providence, RI 02912; and Department of Biology, Morehouse College, 830 Westview Drive, S.W., Atlanta, GA 30314.
SourceAntimicrob Agents Chemother 2009 Aug 17.
AbstractChloramphenicol, florfenicol, and thiamphenicol are used as antibacterial drugs in clinical and veterinary medicine. Two efflux pumps of the major facilitator superfamily (MFS) encoded by the cmlR1 and cmlR2 genes mediate resistance to these antibiotics in Streptomyces coelicolor, a close relative of Mycobacterium tuberculosis. Transcription of both genes was observed by reverse transcription-polymerase chain reaction. Disruption of cmlR1 decreased the chloramphenicol minimal inhibitory concentration (MIC) 1.6 fold, while disruption of cmlR2 lowered the MIC 16-fold. The chloramphenicol MIC of wild-type S. coelicolor decreased four-fold and eight-fold in the presence of reserpine and Phe-Arg-beta-naphthylamide, respectively. These compounds are known to potentiate the activity of some antibacterial drugs via efflux pump inhibition. While reserpine is known to potentiate drug activity against Gram-positive bacteria, this is the first time that Phe-Arg-beta-naphthylamide has been shown to potentiate drug activity against a Gram-positive bacterium.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19687245
  
Advertise on this site.